Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleOracleRed Hat
CEO ReviewCompany Review

The Silicon Review Asia

Emcure led by Humayun Dhanrajgir-Finding success through innovation and technology in the field of Research and Development

The Silicon Review
September, 2019


The pharmaceutical enterprise is setting up new traits in the discipline of pharmacy and biological sciences. the primary is to find out and expand new capsules and to bring them into the market. The pharmaceutical enterprise targets to herald new discoveries which include vaccines, drugs, and different widespread drugs. It mainly deals with medicinal drugs and medical gadgets. They do keep patenting rights on certain medicines; they also carry out efficient drug testing, drug protection exams, and advertising and marketing of the newly formulated pills. they also play a pivotal function in drug concentrated on and drug designing.

The pharmaceutical enterprise plays a important role in the area of life Sciences. One's any such pioneer pharmaceutical industry that is leading with an example is Emcure, centered at Pune in West India. The company changed into included as Emcure prescription drugs non-public confined on April 16, 1981. The call of the firm embodies the reason and core belief of the agency that's to make powerful medicine to cure patients, to steer more healthy and happier lives.

The firm is ranked as the 12th biggest pharmaceutical organization in India in phrases of market percentage, which is primarily based on the domestic sales of pharmaceutical products. The company believes that there may be a competitive advantage in the domestic market lies. The employer has its presence in all fundamental healing regions like blood-associated, cardiology, analgesics, HIV, gynecology, nephrology, Anti-infective, vitamins, and nutrient product.

Main Objectives

The company believes in integrity, innovation, teamwork, respecting the man worker, fee-driven assets, and pleasant and most significantly they recognition on its patients. these are the center values that are observed by means of the organization.


The main vision of the firm is to emerge as a global leader, which offershigh fine and fee-effective healthcare services.

Facilities provided

Research and Development (R&D)

The in-house studies and development abilities of the company have enabled us to take innovation and era to the following stage internationally. The crew is one of the cornerstones of the operations and has contributed drastically to the Indian pharmaceutical enterprise.

Manufacturing unit

Emcure’s manufacturing sectors are unfold across eleven international-magnificence manufacturing facilities and are ranked as the great pharmaceutical industry among other international leaders. The company also has API manufacturing facilities which help in constructing integrity inside the area of exceptional and value manipulate.

The facilities have the capability to manufacture various pharmaceutical dosage forms such as;

Solid Orals: the firm produces a extensive range of strong orals like dissolvable and chewable pills, tough and soft-shelled capsules with a managed release and specific drug focused on.

Injectable: the enterprise handles various packaging codecs like- prefilled syringes, lyophilized as well as injectable centers. The company additionally produces cancer capsules which have complex mechanisms.

APIs: the firm manufactures awesome APIs like intermediates, iron compounds, preferred-motive APIs, and cytotoxins.

Milestones achieved

obtained Marcan pharmaceuticals Inc. in Canada, obtained Bharadwaj Pharma GMBH in Germany, multiplied the employer inside the US to decorate manufacturing facility, Sanand Injectable facility started out USFDA approval of Sanand and F-II, etc.

Current Research

Emcure is the best pharmaceutical production organization in India. The company is targeted on studies. The studies and improvement crew is created from more than 500 scientists quite qualifies in their respective subjects and many studies pupils. The group is devoted to growing complex APIs, formulations, and biosimilars via using chemistry, biologics, analytical, regulatory, and intellectual assets knowledge.

The staunch behind the domicile of Emcure

Humayun Dhanrajgir, the Chairman and Director of Emcure in view that 2000 and a pioneer inside the discipline of chemical engineering and pharmaceuticals. He has held numerous senior control positions together with the position of the vice-chairman and the handling director of Glaxo India limited. He has additionally held the location of the dealing with director of Kodak India confined. He has also served because the president of the agency of pharmaceutical manufacturers of India in 1992 and changed into additionally a member of the Bombay Chamber of commerce and enterprise. he is a member of worldwide advisory board of Asian center for company governance and sustainability. he is a graduate in Chemical Engineering from Loughborough university, uk.

“Wherever the art of medicine is loved, there is also a love of humanity.”


Pine Labs Reaffirms its Commitment to Indian Payments Space with Qfix Acquisition

HDFC financial institution is Qfix's predominant distribution partner Pine Labs has announced that it has received Qfix, a Mumbai-based online payments startup. This acquisi...

Salesforce Expands into Thailand, Opens Office in Bangkok

Salesforce has introduced permanent presence in Thailand through launching its new office inside the country’s capital, Bangkok. The everlasting presence wi...

GMLL is expected to soon add two more stores to its retail arm ‘Price Mantra’

Garment Mantra life-style, a famous name in the Indian style retail section, currently made an assertion that the employer is expanding its retail ...

Tariff plans will cost higher from the next financial year as telecom companies are gearing up to increase rates

The continuing Covid pandemic had notably expanded the variety of cell and internet users worldwide. The high quantity of usage is expected to drop...